Nitric oxide, chronic inflammation and autoimmunity

Immunology Letters

Volumn 111, Issue 1, 2007, Pages 1-5

  Nagy, György ^a   Clark, Joanna M ^b   Buzás, Edit I ^a   Gorman, Claire L ^b   Cope, Andrew P ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Nitric oxide; Rheumatoid arthritis; Systemic lupus erythematosus

Indexed keywords

GUANYLATE CYCLASE; NITRIC OXIDE; T LYMPHOCYTE RECEPTOR;

APOPTOSIS; AUTOIMMUNITY; CHRONIC INFLAMMATION; EFFECTOR CELL; ENZYME ACTIVATION; HUMAN; LYMPHOCYTE DIFFERENTIATION; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SECOND MESSENGER; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION;

ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; HUMANS; INFLAMMATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; NITRIC OXIDE; T-LYMPHOCYTES;

EID: 34347348956     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2007.04.013     Document Type: Review

References (37)

1. Brown C.G. Nitric oxide and mitochondrial respiration. Biochim Biophys Acta 1411 (1999) 351-369
2. Beltran B., Mathur A., Duchen M.R., Erusalimsky J.D., and Moncada S. The effect of nitric oxide on cell respiration: a key to understanding its role in cell survival or death. PNAS 26 (2000) 14602-14607
3. Bredt D.S. Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic Res 31 (1999) 577-596
4. 2+- and redox-dependent production of nitric oxide. J Immunol 171 (2003) 5188-5197
5. van't Hof R.J., and Ralston S.H. Nitric oxide and bone. Immunology 103 (2001) 255-261
6. Beltran B., Quintero M., Gracia-Zaragoza E., O'Connor E., Esplugues J.V., and Moncada S. Inhibition of mitochondrial respiration by endogenous nitric oxide: a critical step in Fas signaling. PNAS 13 (2002) 8892-8897
7. Kim Y.M., Bombeck C.A., and Billiar T.R. Nitric oxide as a bifunctional regulator of apoptosis. Circ Res 19 (1999) 253-256
8. Chung H.T., Pae H.O., Choi B.M., Billiar T.R., and Kim Y.M. Nitric oxide as a bioregulator of apoptosis. Biochem Biophys Res Commun 282 (2001) 1075-1079
9. Mallis R.J., Buss J.E., and Thomas J.A. Oxidative modification of H-ras: S-thiolation and S-nitrosylation of reactive cysteines. Biochem J 355 (2001) 145-153
10. Gow A.J., Farkouh C.R., Munson D.A., Posencheg M.A., and Ischiropoulos H. Biological significance of nitric oxide-mediated protein modifications. Am J Physiol Lung Cell Mol Physiol 287 (2004) L262-L268
11. Nisoli E., Clementi E., and Paolucci C. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 299 (2003) 896-899
12. 2+ signaling profile of lupus T cells. J Immunol 173 (2004) 3676-3683
13. Nagy G., Koncz A., Philips P.E., and Perl A. Mitochondrial signal transduction abnormalities in systemic lupus erythematosus. Curr Immunol Rev 1 (2005) 61-67
14. Perl A., Gergely Jr. P., Nagy G., Koncz A., and Banki K. Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity. Trends Immunol 25 (2004) 360-367
15. Perl A., Nagy G., Gergely P., Puskas F., Qian Y., and Banki K. Apoptosis and mitochondrial dysfunction in lymphocytes of patients with systemic lupus erythematosus. Methods Mol Med 102 (2004) 87-114
16. Kammer G.M., Perl A., Richardson B.C., and Tsokos G.C. Abnormal T cell signal transduction in systemic lupus erythematosus. Arthritis Rheum 46 (2002) 1139-1154
17. 2+ liaison. Sci STKE 13 (2004) 215-217
18. In: Ruddy S., Harris E.D., Sledge C.B., Budd R.C., Sergent J.S., and Kelley W.N. (Eds). Kelley's textbook of rheumatology. 7th ed. (2005), Elsevier
19. Onur O., Akinci A.S., Akbiyik F., and Unsal I. Elevated levels of nitrate in rheumatoid arthritis. Rheumatol Int 20 (2001) 154-158
20. Choi J.W. Nitric oxide production is increased in patients with rheumatoid arthritis but does not correlate with laboratory parameters of disease activity. Clin Chim Acta 336 (2003) 83-87
21. Gonzalez Gay M.A., Llorca J., Sanchez E., Lopez-Nevot M.A., Amoli M.M., Garcia-Porrua C., et al. Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain. Rheumatology (Oxford) 43 (2004) 1182-1185
22. van't Hof R.J., Armour K.J., Smith L.M., Armour K.E., Wei X.Q., Liew F.Y., et al. Requirement of the inducible nitric oxide synthase pathway for IL-1-induced osteoclastic bone resorption. PNAS 97 (2000) 7993-7998
23. Perkins D.J., St Clair E.W., Misukonis M.A., and Weinberg J.B. Reduction of NOS2 overexpression in rheumatoid arthritis patients treated with anti-tumor necrosis factor alpha monoclonal antibody (cA2). Arthritis Rheum 41 (1998) 2205-2210
24. McCartney-Francis N., Allen B.J., and Mizel D.E. Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 178 (1993) 749-754
25. Wang B., Ma L., Tao X., and Lipsky P.E. Triptolide, an active component of the Chinese herbal remedy Tripterygium wilfordii Hook F, inhibits production of nitric oxide by decreasing inducible nitric oxide synthase gene transcription. Arthritis Rheum 50 (2004) 2995-3003
26. Matsuda M., Ulfgren A.K., Lenkei R., Petersson M., Ochoa A.C., Lindblad S., et al. Decreased expression of signal-transducing CD3 zeta chains in T cells from the joints and peripheral blood of rheumatoid arthritis patients. Scand J Immunol 47 (1998) 254-262
27. Clark J.M., Annenkov A.E., Panesar M., Isomaki P., Chernajovsky Y., and Cope A.P. T cell receptor zeta reconstitution fails to restore responses of T cells rendered hyporesponsive by tumor necrosis factor alpha. PNAS 101 (2004) 1696-1701
28. Kirchgessner H., Dietrich J., Scherer J., Isomaki P., Korinek V., Hilgert I., et al. The transmembrane adaptor protein TRIM regulates T cell receptor (TCR) expression and TCR-mediated signaling via an association with the TCR zeta chain. J Exp Med 193 (2001) 1269-1284
29. Gringhuis S.I., Leow A., Papendrecht-van der Voort E.A.M., Remans P.H.J., Breedveld F.C., and Verweij C.L. Displacement of linker for activation of T cells from the plasma membrane due to redox balance alterations results in hyporesponsiveness of synovial fluid T lymphocytes in rheumatoid arthritis. J Immunol 164 (2000) 2170-2179
30. Maurice M.M., Nakamura H., van der Voort E.A., van Vliet A.I., Staal F.J., Tak P.P., et al. Evidence for the role of an altered redox state in hyporesponsiveness of synovial T cells in rheumatoid arthritis. J Immunol 158 (1997) 1458-1465
31. Verweij C.L., and Gringhuis S.I. Oxidants and tyrosine phosphorylation: role of acute and chronic oxidative stress in T-and B-lymphocyte signaling. Antioxid Redox Signal 4 (2002) 543-551
32. Remans P.H., Gringhuis S.I., van Laar J.M., Sanders M.E., Papendrecht-van der Voort E.A., Zwartkruis F.J., et al. Rap1 signaling is required for suppression of Ras-generated reactive oxygen species and protection against oxidative stress in T lymphocytes. J Immunol 173 (2004) 920-931
33. Farrell A.J., Blake D.R., and Palmar R.M.J. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 51 (1992) 1219-1222
34. Leist M., Single B., Castoldi A.F., Kuhnle S., and Nicotera P. Intracellular adenisine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 185 (1997) 1481-1486
35. Melino G., Catani M.V., Corazzari M., Guerrieri P., and Bernassola F. Nitric oxide can inhibit apoptosis or switch it into necrosis. Cell Mol Life Sci 57 (2000) 612-622
36. Rodriguez P.C., Zea A.H., Culotta K.S., Zabaleta J., Ochoa J.B., and Ochoa A.C. Regulation of T cell receptor CD3 zeta chain expression by l-arginine. J Biol Chem 277 (2002) 21123-21129
37. Cemerski S., Cantagrel A., Van Meerwijk J.P., and Romagnoli P. Reactive oxygen species differentially affect T cell receptor-signaling pathways. J Biol Chem 277 (2002) 19585-19593